Propiedad y actividad de insiders de Kezar Life Sciences, Inc. (KZR): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $7.29 |
| Capitalización | $54M |
| Bolsa | NASDAQ |
| País | US |
Operaciones Recientes de Insiders
| Fecha | Insider | Tipo | Acciones | Valor |
|---|---|---|---|---|
| 2026-05-11 | Wallace Courtney | D-Return | 3,500 | $92K |
| 2026-05-11 | Wallace Courtney | D-Return | 5,000 | $34K |
| 2026-05-11 | Wallace Courtney | D-Return | 5,000 | $22K |
| 2026-05-11 | Wallace Courtney | D-Return | 2,600 | $59K |
| 2026-05-11 | Schiller Mark C. | U-Tender | 2,739 | $19K |
| 2026-05-11 | Schiller Mark C. | D-Return | 25,000 | $233K |
| 2026-05-11 | Schiller Mark C. | D-Return | 24,500 | $161K |
| 2026-05-11 | Schiller Mark C. | D-Return | 12,000 | $76K |
| 2026-05-11 | Schiller Mark C. | D-Return | 16,499 | $376K |
| 2026-05-11 | Klearman Micki | D-Return | 3,500 | $92K |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $9.7M | $51.0M | $24.2M | $15.0M | $21.2M | $62.9M | $40.5M | $35.5M | $41.7M | $71.9M |
| Inversiones a Corto | 0 | 0 | $83.2M | $63.3M | $119.2M | $145.5M | $236.1M | $165.9M | $90.5M | 0 |
| Cuentas por Cobrar | 0 | 0 | 0 | $642000 | $766000 | 0 | 0 | $2.3M | $424000 | $1.9M |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $10.5M | $52.3M | $109.8M | $81.1M | $144.8M | $211.7M | $285.7M | $206.9M | $137.5M | $75.7M |
| Inmovilizado Material | $862000 | $1.5M | $4.6M | $8.1M | $6.7M | $6.0M | $13.2M | $8.7M | $4.8M | $915000 |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $11.4M | $54.2M | $114.7M | $89.5M | $151.8M | $217.9M | $299.6M | $221.2M | $144.7M | $76.6M |
| Cuentas por Pagar | $466000 | $547000 | $193000 | $823000 | $2.4M | $2.0M | $2.5M | $8.3M | $3.7M | $507000 |
| Deuda a Corto | 0 | 0 | 0 | $900000 | $1.0M | 0 | 0 | 0 | $5.2M | 0 |
| Pasivos Corrientes | $651000 | $1.5M | $3.3M | $6.0M | $6.4M | $8.2M | $11.0M | $17.7M | $20.3M | $6.6M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | $9.6M | $9.8M | $10.1M | $5.1M | 0 |
| Pasivos Totales | $28.9M | $79.9M | $5.9M | $11.5M | $10.9M | $21.1M | $29.7M | $33.7M | $27.8M | $6.6M |
| Reservas | -$17.5M | -$26.0M | -$49.2M | -$84.3M | -$126.0M | -$180.7M | -$248.9M | -$350.8M | -$434.5M | -$490.5M |
| Patrimonio Neto | -$17.4M | -$25.7M | $108.8M | $78.0M | $141.0M | $196.9M | $269.9M | $187.6M | $116.9M | $70.1M |
| Deuda Total | 0 | 0 | 0 | $6.4M | $5.5M | $14.0M | $21.3M | $18.9M | $16.2M | $2.3M |
| Deuda Neta | -$9.7M | -$51.0M | -$107.4M | -$71.8M | -$135.0M | -$194.3M | -$255.3M | -$182.4M | -$116.1M | -$69.6M |
| Capital Circulante | $9.8M | $50.8M | $106.5M | $75.1M | $138.4M | $203.4M | $274.7M | $189.2M | $117.2M | $69.2M |
Salud financiera
| Deuda / Patrimonio | 0.02 |
| Ratio corriente | 24.46 |
| Piotroski F-Score | 5 |
| Altman Z-Score | -5.93 |
Rentabilidad
| Rentabilidad sobre capital | -79.96% |
| Rentabilidad sobre capital invertido | -72.20% |
| Rentabilidad sobre activos | -73.11% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Empresas relacionadas: CCCC · CRNX · ERAS · EWTX · REPL · SRRK · STRO
Explorar sector: Healthcare · Biotechnology
Más secciones de KZR: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones